USP Comment Letter: Submitted to FDA on Nitrosamines Guidance (2020)

Submitted on November 10, 2020 - USP Comment Letter to FDA on FDA Guidance for Industry, Control of Nitrosamine Impurities in Human Drugs. Docket No. FDA-2020-D-1530

2010-11-10-USP-Comments-to-FDA-on-Nitrosamines-Guidance-FDA.pdf (259.17 KB)